Completed NA INTERVENTIONAL 2-arm NCT02938091

Dietary Modulation of Hepatic Lipase (LIPC) -514 C/T Variant Associations With Lipids and Glucose

Hepatic Lipase Variant -514 C/T in a High Fat vs. Low Fat Diet for Cardio-metabolic Outcomes: A Crossover Randomized Dietary Intervention Trial

Sponsor: Tufts University

Conditions Dyslipidemia Impaired Glucose Tolerance

Interventions High-fat diet Low-fat diet

Updated 5 times since 2017 Last updated: Oct 17, 2016 Started: Jan 31, 2008 Primary completion: Jul 31, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02938091, this NA trial focuses on Dyslipidemia and Impaired Glucose Tolerance and remains completed. Sponsored by Tufts University, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tufts University

Data source: Tufts University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.